Search

everythinglearnresearchcommunity

for

Search:↓

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Type I interferons play a key role in the development of various skin diseases.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Longer hair loss leads to more severe CCCA; early treatment and avoiding damaging hairstyles help regrowth.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

COVID-19 may harm male fertility and damage the reproductive system.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The pandemic changed how often certain skin conditions were diagnosed.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Oral minoxidil can increase or maintain hair thickness in most people with lichen planopilaris, with mild side effects.

Dengue virus can infect human hair follicle cells and may cause hair loss.